These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

614 related items for PubMed ID: 17210380

  • 1. Endovascular treatment of long lesions of the superficial femoral artery: results from a multicenter registry of a spiral, covered polytetrafluoroethylene stent.
    Lenti M, Cieri E, De Rango P, Pozzilli P, Coscarella C, Bertoglio C, Troiani R, Cao P.
    J Vasc Surg; 2007 Jan; 45(1):32-9. PubMed ID: 17210380
    [Abstract] [Full Text] [Related]

  • 2. Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
    McQuade K, Gable D, Hohman S, Pearl G, Theune B.
    J Vasc Surg; 2009 Jan; 49(1):109-15, 116.e1-9; discussion 116. PubMed ID: 19028055
    [Abstract] [Full Text] [Related]

  • 3. Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
    McQuade K, Gable D, Pearl G, Theune B, Black S.
    J Vasc Surg; 2010 Sep; 52(3):584-90; discussion 590-1, 591.e1-591.e7. PubMed ID: 20598480
    [Abstract] [Full Text] [Related]

  • 4. Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease.
    Geraghty PJ, Mewissen MW, Jaff MR, Ansel GM, VIBRANT Investigators.
    J Vasc Surg; 2013 Aug; 58(2):386-95.e4. PubMed ID: 23676191
    [Abstract] [Full Text] [Related]

  • 5. Management of flush superficial femoral artery occlusions with combined open femoral endarterectomy and endovascular femoral-popliteal angioplasty and stent-grafting.
    Hayes DJ, Dougherty MJ, Calligaro KD.
    Ann Vasc Surg; 2011 May; 25(4):559.e19-23. PubMed ID: 21549939
    [Abstract] [Full Text] [Related]

  • 6. Randomized comparison of percutaneous Viabahn stent grafts vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral arterial occlusive disease.
    Kedora J, Hohmann S, Garrett W, Munschaur C, Theune B, Gable D.
    J Vasc Surg; 2007 Jan; 45(1):10-6; discussion 16. PubMed ID: 17126520
    [Abstract] [Full Text] [Related]

  • 7. Duplex-guided endovascular treatment for occlusive and stenotic lesions of the femoral-popliteal arterial segment: a comparative study in the first 253 cases.
    Ascher E, Marks NA, Hingorani AP, Schutzer RW, Mutyala M.
    J Vasc Surg; 2006 Dec; 44(6):1230-7; discussion 1237-8. PubMed ID: 17055689
    [Abstract] [Full Text] [Related]

  • 8. Heparin-bonded stent-graft for the treatment of TASC II C and D femoropopliteal lesions: the Viabahn-25 cm trial.
    Zeller T, Peeters P, Bosiers M, Lammer J, Brechtel K, Scheinert D, Rastan A, Noory E, Beschorner U.
    J Endovasc Ther; 2014 Dec; 21(6):765-74. PubMed ID: 25453876
    [Abstract] [Full Text] [Related]

  • 9. Multi centre study to assess the feasibility of a new covered stent and delivery system in combination with remote superficial femoral artery endarterectomy (RSFAE).
    Knight JS, Smeets L, Morris GE, Moll FL.
    Eur J Vasc Endovasc Surg; 2005 Mar; 29(3):287-94. PubMed ID: 15694803
    [Abstract] [Full Text] [Related]

  • 10. Long-term outcomes and predictors of iliac angioplasty with selective stenting.
    Kudo T, Chandra FA, Ahn SS.
    J Vasc Surg; 2005 Sep; 42(3):466-75. PubMed ID: 16171589
    [Abstract] [Full Text] [Related]

  • 11. Safety and efficacy of antiplatelet/anticoagulation regimens after Viabahn stent graft treatment for femoropopliteal occlusive disease.
    Ullery BW, Tran K, Itoga N, Casey K, Dalman RL, Lee JT.
    J Vasc Surg; 2015 Jun; 61(6):1479-88. PubMed ID: 25704407
    [Abstract] [Full Text] [Related]

  • 12. Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease).
    Lammer J, Zeller T, Hausegger KA, Schaefer PJ, Gschwendtner M, Mueller-Huelsbeck S, Rand T, Funovics M, Wolf F, Rastan A, Gschwandtner M, Puchner S, Ristl R, Schoder M.
    J Am Coll Cardiol; 2013 Oct 08; 62(15):1320-7. PubMed ID: 23831445
    [Abstract] [Full Text] [Related]

  • 13. Safety and efficacy of the EPIC™ nitinol vascular stent system for the treatment of lesions located in the superficial femoral artery: prospective and multicentric trial.
    Nasser F, Kambara A, Abath C, Cavalcanti D, Barros I, Pires N, Rivera M, Neser A, Ingrund J, Burihan M, Silveira P, Galego G, Bortoluzzi C, Franklin R, Bosiers M, Deloose K, Razuk A, Caffaro R, Karakhanian WK, Park J, Lopes C, Pinto D, Bez L, Lopes R, Mourão A, Kleinsorge G.
    J Cardiovasc Surg (Torino); 2017 Jun 08; 58(3):409-415. PubMed ID: 25731858
    [Abstract] [Full Text] [Related]

  • 14. Results of heparin-bonded ePTFE-covered stents for chronic occlusive superficial femoral artery disease.
    Lensvelt MM, Fritschy WM, van Oostayen JA, Holewijn S, Zeebregts CJ, Reijnen MM.
    J Vasc Surg; 2012 Jul 08; 56(1):118-25. PubMed ID: 22342154
    [Abstract] [Full Text] [Related]

  • 15. Long-term results of the Japanese multicenter Viabahn trial of heparin bonded endovascular stent grafts for long and complex lesions in the superficial femoral artery.
    Ohki T, Kichikawa K, Yokoi H, Iida O, Yamaoka T, Maeda K, Kanaoka Y.
    J Vasc Surg; 2021 Dec 08; 74(6):1958-1967.e2. PubMed ID: 34182032
    [Abstract] [Full Text] [Related]

  • 16. Outcomes of the Japanese multicenter Viabahn trial of endovascular stent grafting for superficial femoral artery lesions.
    Ohki T, Kichikawa K, Yokoi H, Uematsu M, Yamaoka T, Maeda K, Kanaoka Y.
    J Vasc Surg; 2017 Jul 08; 66(1):130-142.e1. PubMed ID: 28400218
    [Abstract] [Full Text] [Related]

  • 17. A comparison of the standard bolia technique versus subintimal recanalization plus Viabahn stent graft in the management of femoro-popliteal occlusions.
    Boufi M, Dona B, Orsini B, Auquier P, Hartung O, Alimi YS.
    J Vasc Surg; 2010 Nov 08; 52(5):1211-7. PubMed ID: 20692789
    [Abstract] [Full Text] [Related]

  • 18. Randomized, multicenter study comparing expanded polytetrafluoroethylene-covered endoprosthesis placement with percutaneous transluminal angioplasty in the treatment of superficial femoral artery occlusive disease.
    Saxon RR, Dake MD, Volgelzang RL, Katzen BT, Becker GJ.
    J Vasc Interv Radiol; 2008 Jun 08; 19(6):823-32. PubMed ID: 18503895
    [Abstract] [Full Text] [Related]

  • 19. Performance of ePTFE-covered endograft in patients with occlusive disease of the superficial femoral artery: a three-year clinical follow-up study.
    Fritschy WM, Kruse RR, Frakking TG, Van Geloven AA, Blomme AM.
    J Cardiovasc Surg (Torino); 2010 Dec 08; 51(6):783-90. PubMed ID: 21124274
    [Abstract] [Full Text] [Related]

  • 20. Stenting vs above knee polytetrafluoroethylene bypass for TransAtlantic Inter-Society Consensus-II C and D superficial femoral artery disease.
    Dosluoglu HH, Cherr GS, Lall P, Harris LM, Dryjski ML.
    J Vasc Surg; 2008 Nov 08; 48(5):1166-74. PubMed ID: 18692357
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.